|
US3658967A
(en)
|
1966-06-23 |
1972-04-25 |
Ici Ltd |
Carboxylic acid derivatives for lowering the concentration of triglycerides in the blood
|
|
GB1140748A
(en)
|
1966-06-23 |
1969-01-22 |
Ici Ltd |
New carboxylic acid derivatives
|
|
CH480308A
(de)
|
1966-08-11 |
1969-10-31 |
Ciba Geigy |
Verfahren zur Herstellung von Thiosemicarbazid-Verbindungen
|
|
US4049663A
(en)
|
1972-06-06 |
1977-09-20 |
Allen & Hanburys Limited |
Ethylene diamine derivatives
|
|
DE2460891C2
(de)
|
1974-12-21 |
1982-09-23 |
Gödecke AG, 1000 Berlin |
1-Aminomethyl-1-cycloalkanessigsäuren und deren Ester, Verfahren zu deren Herstellung und diese Verbindungen enthaltende Arzneimittel
|
|
US4087544A
(en)
|
1974-12-21 |
1978-05-02 |
Warner-Lambert Company |
Treatment of cranial dysfunctions using novel cyclic amino acids
|
|
US4311853A
(en)
|
1979-02-06 |
1982-01-19 |
The Radiochemical Centre Limited |
Selenium derivatives of thyroxine and tri-iodothyronine
|
|
DE3010599A1
(de)
|
1979-03-22 |
1980-10-09 |
Continental Pharma |
Derivate von glycinamid, deren herstellung und verwendung
|
|
US4267354A
(en)
|
1979-04-25 |
1981-05-12 |
E. R. Squibb & Sons, Inc. |
Substituted amides having antiinflammatory activity and intermediates
|
|
PL124029B1
(en)
|
1979-06-01 |
1982-12-31 |
Wellcome Found |
Process for preparing novel derivatives of 1,2,4-triazine
|
|
ZA805476B
(en)
|
1979-09-26 |
1981-11-25 |
Robins Co Inc A H |
2-amino-3-benzoyl-phenylacetamides and cyclic homologues
|
|
FR2480747A1
(fr)
|
1980-04-17 |
1981-10-23 |
Roques Bernard |
Derives d'acides amines et leur application therapeutique
|
|
EP0144853B1
(en)
|
1983-11-21 |
1990-09-26 |
Fujisawa Pharmaceutical Co., Ltd. |
Semicarbazide derivatives, processes for preparation thereof and pharmaceutical composition comprising the same
|
|
US4725619A
(en)
|
1985-04-16 |
1988-02-16 |
Usv Pharmaceutical Corporation |
Aryl and heteroaryl ethers as agents for the treatment of hypersensitive ailments
|
|
US4631287A
(en)
|
1985-04-16 |
1986-12-23 |
Usv Pharmaceutical Corp. |
Aryl and heteroaryl ethers as agents for the treatment of hypersensitive ailments
|
|
US4839369A
(en)
|
1985-04-16 |
1989-06-13 |
Rorer Pharmaceutical Corporation |
Aryl and heteroaryl ethers as agents for the treatment of hypersensitive ailments
|
|
GB8714901D0
(en)
|
1986-07-23 |
1987-07-29 |
Ici Plc |
Amide derivatives
|
|
GB2216515A
(en)
|
1988-03-04 |
1989-10-11 |
Nippon Shinyaku Co Ltd |
Acylphenol derivatives
|
|
US4894476A
(en)
|
1988-05-02 |
1990-01-16 |
Warner-Lambert Company |
Gabapentin monohydrate and a process for producing the same
|
|
FR2639225B1
(fr)
|
1988-11-21 |
1993-05-21 |
Centre Nat Rech Scient |
Compositions pharmaceutiques pour la neuroprotection contenant des arylcyclohexylamines
|
|
IL94466A
(en)
|
1989-05-25 |
1995-01-24 |
Erba Carlo Spa |
Pharmaceutical preparations containing the history of A-amino carboxamide N-phenylalkyl are converted into such new compounds and their preparation
|
|
DE3928488A1
(de)
|
1989-08-29 |
1991-03-07 |
Standard Elektrik Lorenz Ag |
Interferometrisches messsystem
|
|
US5025035A
(en)
|
1990-10-12 |
1991-06-18 |
Warner-Lambert Company |
Method of treating depression
|
|
DE69224861T2
(de)
|
1991-07-30 |
1998-08-06 |
Korea Res Inst Chem Tech |
Neue Phenylacetamidderivate und Verfahren zu ihrer Herstellung
|
|
GB9203483D0
(en)
|
1992-02-19 |
1992-04-08 |
Wellcome Found |
Anti-inflammatory compounds
|
|
US5330515A
(en)
|
1992-06-17 |
1994-07-19 |
Cyberonics, Inc. |
Treatment of pain by vagal afferent stimulation
|
|
US5256669A
(en)
|
1992-08-07 |
1993-10-26 |
Aminotek Sciences, Inc. |
Methods and compositions for treating acute or chronic pain and drug addiction
|
|
US5498610A
(en)
|
1992-11-06 |
1996-03-12 |
Pfizer Inc. |
Neuroprotective indolone and related derivatives
|
|
GB9306886D0
(en)
|
1993-04-01 |
1993-05-26 |
Erba Carlo Spa |
Substituted (arylakoxybenzyl) aminopropanamide derivatives and process for their preparation
|
|
GB9306899D0
(en)
|
1993-04-01 |
1993-05-26 |
Erba Carlo Spa |
Substituted (arylalkylaminobenzyl) aminopropionamide derivatives and process for their preparation
|
|
US5475007A
(en)
|
1993-05-28 |
1995-12-12 |
The Regents Of The University Of California |
1,2,3,4-tetrahydroquinoline-2,3,4-trione-3 or 4-oximes and the use thereof
|
|
ZA953078B
(en)
|
1994-04-28 |
1996-01-05 |
Alza Corp |
Effective therapy for epilepsies
|
|
US5482964A
(en)
|
1994-10-11 |
1996-01-09 |
Warner-Lambert Company |
Substituted phenoxyhydroxypropyl amines as central nervous system agents
|
|
US5541204A
(en)
|
1994-12-02 |
1996-07-30 |
Bristol-Myers Squibb Company |
Aryloxypropanolamine β 3 adrenergic agonists
|
|
GB9426102D0
(en)
|
1994-12-23 |
1995-02-22 |
Merck Sharp & Dohme |
Pharmacuetical compositions
|
|
KR0147963B1
(ko)
|
1995-01-10 |
1998-08-17 |
강박광 |
엔-아릴알킬페닐아세트아미드 유도체와 그의 제조방법
|
|
US5849737A
(en)
|
1995-04-14 |
1998-12-15 |
The Regents Of The University Of California |
Compositions and methods for treating pain
|
|
US5741818A
(en)
|
1995-06-07 |
1998-04-21 |
University Of Saskatchewan |
Semicarbazones having CNS activity and pharmaceutical preparations containing same
|
|
GB9512854D0
(en)
|
1995-06-23 |
1995-08-23 |
Wellcome Found |
Novel formulation
|
|
US5795864A
(en)
|
1995-06-27 |
1998-08-18 |
Neurex Corporation |
Stable omega conopetide formulations
|
|
GB9515411D0
(en)
|
1995-07-27 |
1995-09-27 |
Pharmacia Spa |
N-(4-substituted-benzyl)-2-aminolactam derivatives
|
|
GB9515412D0
(en)
|
1995-07-27 |
1995-09-27 |
Pharmacia Spa |
2-(4-substituted)-benzylamino-2-methyl-propanamide derivatives
|
|
US5688830A
(en)
|
1996-01-25 |
1997-11-18 |
Syntex (U.S.A.) Inc. |
Treatment of neuropathic pain
|
|
US6372792B1
(en)
*
|
1996-04-26 |
2002-04-16 |
Guy Chouinard |
Method for treating anxiety, anxiety disorders and insomnia
|
|
EP0934061B3
(en)
*
|
1996-07-24 |
2015-01-21 |
Warner-Lambert Company LLC |
Isobutylgaba and its derivatives for the treatment of pain
|
|
DE69733081T2
(de)
|
1996-08-23 |
2006-05-11 |
Endo Pharmaceuticals Inc. (n.d.Ges.d. Staates Delaware) |
Antikonvulsive mitteln enthaltende zubereitung zur behandlung von neuropathischen schmerzen
|
|
US6172085B1
(en)
|
1996-08-29 |
2001-01-09 |
Takeda Chemical Industries, Ltd. |
Cyclic ether compounds as sodium channel modulators
|
|
US6290986B1
(en)
|
1996-10-24 |
2001-09-18 |
Pharmaceutical Applications Associates, Llc |
Method and composition for transdermal administration of pharmacologic agents
|
|
EP1132082A1
(en)
*
|
1996-11-05 |
2001-09-12 |
Head Explorer ApS |
Use of substances capable of blocking the production of glutamate for treating tension-type headache
|
|
TW492957B
(en)
|
1996-11-07 |
2002-07-01 |
Novartis Ag |
N-substituted 2-cyanopyrrolidnes
|
|
US6207685B1
(en)
|
1996-12-06 |
2001-03-27 |
Societe De Conseils De Recherches Et D'applications Scientifiques (S.C.R.A.S.) |
Therapeutic application of a thienycyclohexylamine derivative
|
|
FR2756738B1
(fr)
|
1996-12-06 |
1999-02-12 |
Sod Conseils Rech Applic |
Nouvelle application therapeutique d'un derive de la thienylcyclohexylamine
|
|
IL119890A
(en)
|
1996-12-24 |
2002-03-10 |
Teva Pharma |
Gabapentin form iii and preparation of gabapentin form ii
|
|
GB9706730D0
(en)
|
1997-04-03 |
1997-05-21 |
Pharmacia & Upjohn Spa |
2-[(3-substituted)-5-Isoxazolymethylaminojalkanamid derivatives
|
|
ATE289295T1
(de)
|
1997-04-22 |
2005-03-15 |
Euro Celtique Sa |
Die verwendung von durch carbozyklische und heterozyklische reste substituierte semicarbazonen und thiosemicarbazonen als natriumkanalblocker
|
|
AU8668598A
(en)
|
1997-08-20 |
1999-03-08 |
University Of Oklahoma, The |
Gaba analogs to prevent and treat gastrointestinal damage
|
|
WO1999012537A1
(en)
*
|
1997-09-08 |
1999-03-18 |
Warner-Lambert Company |
Analgesic compositions comprising anti-epileptic compounds and methods of using same
|
|
EP2201945B1
(en)
|
1997-11-21 |
2013-03-06 |
Purdue Neuroscience Company |
Use of substituted 2-aminoacetamides for treating or ameliorating anxiety
|
|
GB9727521D0
(en)
|
1997-12-31 |
1998-02-25 |
Pharmacia & Upjohn Spa |
Substituted 2-benzylamino-2-phenyl-acetamide compounds
|
|
GB9727523D0
(en)
|
1997-12-31 |
1998-02-25 |
Pharmacia & Upjohn Spa |
Alpha-aminoamide derivatives useful as analgesic agents
|
|
CA2309354A1
(en)
|
1998-01-23 |
1999-07-29 |
Leslie Magnus-Miller |
Gabapentin and its derivatives for the treatment of muscular and skeletal pain
|
|
US5905069A
(en)
|
1998-01-26 |
1999-05-18 |
The General Hospital Corporation |
Methods of decreasing or preventing pain using spicamycin or derivatives thereof
|
|
AU754681B2
(en)
|
1998-02-04 |
2002-11-21 |
Euro-Celtique S.A. |
Substituted semicarbazides and the use thereof
|
|
GB9804885D0
(en)
|
1998-03-06 |
1998-04-29 |
Merck Sharp & Dohme |
Therapeutic combination
|
|
ES2137137B1
(es)
|
1998-05-25 |
2000-08-16 |
Medichem Sa |
Nuevo polimorfo de gabapentina no hidratada, su procedimiento de obtencion y su utilizacion para la obtencion de gabapentina de calidad farmaceutica.
|
|
JP2002520300A
(ja)
|
1998-07-09 |
2002-07-09 |
ワーナー−ランバート・カンパニー |
Ｇａｂａ類縁体及び抗ウイルス剤を含んでなる帯状ヘルペスを治療するための医薬組成物
|
|
PL345340A1
(en)
|
1998-07-09 |
2001-12-17 |
Warner Lambert Co |
Compositions comprising gaba analogs and caffeine
|
|
US6281211B1
(en)
|
1999-02-04 |
2001-08-28 |
Euro-Celtique S.A. |
Substituted semicarbazides and the use thereof
|
|
US6451857B1
(en)
|
1999-03-10 |
2002-09-17 |
Warner-Lambert Company |
Analgesic compositions comprising anti-epileptic compounds and methods of using same
|
|
IL145508A0
(en)
|
1999-03-26 |
2002-06-30 |
Euro Celtique Sa |
Aryl substituted pyrazole, imidazole, oxazole, thiazole and pyrrole derivatives and pharmaceutical compositions containing the same
|
|
AU4334900A
(en)
|
1999-04-09 |
2000-11-14 |
Euro-Celtique S.A. |
Sodium channel blocker compositions and the use thereof
|
|
PT1202725E
(pt)
|
1999-07-22 |
2007-07-11 |
Universuty Of Rochester |
Método para tratar sintomas de alteração hormonal, incluindo afrontamentos.
|
|
EP1200086A4
(en)
|
1999-08-04 |
2009-05-27 |
Icagen Inc |
THERAPEUTIC OR PROPHYLACTIC METHODS OF PAIN AND ANXIETY
|
|
US6113915A
(en)
|
1999-10-12 |
2000-09-05 |
Allergan Sales, Inc. |
Methods for treating pain
|
|
GB9930079D0
(en)
*
|
1999-12-20 |
2000-02-09 |
Glaxo Group Ltd |
Medicaments
|
|
CA2413451A1
(en)
|
2000-06-19 |
2001-12-27 |
Merck Frosst Canada & Co. |
Methods of identifying gabab receptor subtype-specific agonists
|
|
EP1229332A3
(en)
|
2001-02-02 |
2004-07-28 |
Warner-Lambert Company |
In vitro assay for testing gabapentinoid activity
|
|
CN1274306C
(zh)
|
2001-09-03 |
2006-09-13 |
纽朗制药有限公司 |
包含加巴喷丁或其类似物和α－氨基酰胺的药物组合物及其止痛应用
|
|
EP1438956A1
(en)
|
2003-01-16 |
2004-07-21 |
Newron Pharmaceuticals S.p.A. |
Alpha-aminoamide derivatives useful as antimigraine agents
|
|
AR044007A1
(es)
|
2003-04-11 |
2005-08-24 |
Newron Pharmaceuticals Inc |
Metodos para el tratamiento de la enfermedad de parkinson
|
|
EP1588704A1
(en)
|
2004-04-22 |
2005-10-26 |
Newron Pharmaceuticals S.p.A. |
Alpha-aminoamide derivatives useful in the treatment of restless legs syndrome and addictive disorders
|
|
RS51411B
(sr)
|
2004-09-10 |
2011-02-28 |
Newron Pharmaceuticals S.P.A. |
Upotreba (r)-(halobenziloksi) benzilamino-propanamida kao selektivnih modulatora natrijumovih i/ili kalcijumovih kanala
|